Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept with Cyclosporine A and Steroids in Heart Transplant
NCT02091414Phase 3Completed
- Sponsor
- Roche
- Start
- Aug 2006
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mycophenolate mofetil in heart transplant rejection, sponsored by Roche. Primary endpoint: Biopsy Proven Acute Rejection at Week 24. Started Aug 2006; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT02091414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091414.